LP157318-9
Elvitegravir
Active
Description
Elvitegravir is an integrase strand transfer innhibitor (INSTI) active against the human immunodeficiency virus (HIV). Therapy with elvitegravir may be used in combination with cobicistat (a CYP3A4 inhibitor), emtricitabine and tenofovir (both nucleoside reverse transcriptase inhibitors). The treatment is often associated with increased alanine aminotransferase (ALT) levels in serum with no reports of clinically apparent liver injury.[NIH LiverTox: Elvitegravir] Source: Regenstrief LOINC
Basic Part Properties
- Part Display Name
- Elvitegravir
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2012-09-13
- Construct for LOINC Short Name
- Elvitegravir
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP157318-9 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP157318-9
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 埃替格韦 Synonyms: 6-(3-Chloro-2-fluorobenzyl)-1-[1(S)-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; |
| es-ES | Spanish (Spain) | Elvitegravir |
| it-IT | Italian (Italy) | Elvitegravir |
| tr-TR | Turkish (Turkey) | Elvitegravir |
| ru-RU | Russian (Russian Federation) | Элвитегравир |
| nl-NL | Dutch (Netherlands) | Elvitegravir |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright